Prenatal exposure to cigarette smoke induces diet- and sex-dependent dyslipidemia and weight gain in adult murine offspring

Environmental Health Perspectives

Volumn 117, Issue 7, 2009, Pages 1042-1048

  Ng, Sheung P ^a   Conklin, Daniel J ^b   Bhatnagar, Aruni ^b   Bolanowski, Duane D ^b   Lyon, Jessica ^a   Zelikoff, Judith T ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b University of Louisville School of Medicine   (United States)

Author keywords

Cardiovascular disease; Cigarette smoke; Dyslipidemia; Fetal basis of adult disease; Fetal insult; Prenatal exposure; Weight gain

Indexed keywords

CIGARETTE SMOKE; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PHOSPHOLIPID; PROTEIN;

ALBUMIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; BODY WEIGHT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; COMPARATIVE STUDY; CONTROLLED STUDY; DIETARY INTAKE; DYSLIPIDEMIA; FEMALE; LIPID DIET; LIPOPROTEIN BLOOD LEVEL; MALE; MOUSE; NONHUMAN; ORGAN WEIGHT; PHOSPHOLIPID BLOOD LEVEL; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROGENY; RISK FACTOR; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN;

ANIMALS; BODY WEIGHT; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIETARY FATS; DYSLIPIDEMIAS; FEMALE; LIPID METABOLISM; LIPIDS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MATERNAL EXPOSURE; MICE; ORGAN SIZE; PREGNANCY; RANDOM ALLOCATION; SEX FACTORS; SMOKING; WEIGHT GAIN;

MURINAE; MUS;

EID: 67650888915     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.0800193     Document Type: Article

References (54)

1. Akisu M, Balim Z, Cetin H, Kosova B, Yalaz M, Topcuoglu N, et al. 2004. The role of angiotensin-converting enzyme and apolipoprotein-E gene polymorphisms on lipid compositions in newborn infants with intrauterine growth restriction. Early Hum Dev 78(2):95-103.
2. Albrecht SA, Maloni JA, Thomas KK, Jones R, Halleran J, Osborne J. 2004. Smoking cessation counseling for pregnant women who smoke: scientific basis for practice for AWHONN's SUCCESS project. J Obstet Gynecol Neonatal Nurs 33:298-305.
3. Al Mamun A, Lewlor DA, Alati R, O'Callaghan MJ, Williams GM, Najman, JM. 2006. Does maternal smoking during pregnancy have a direct effect on future offspring obesity? Evidence from a prospective birth cohort study. Am J Epidemiol 164(4):317-325.
4. American Heart Association. 2006. Heart disease and stroke statistics - 2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 113:e85-e151.
5. Ansell BJ, Fonarow GC, Fogelman AM. 2007. The paradox of dysfunctional high-density lipoprotein. Curr Opin Lipidol 18(4):427-434.
6. Ashakumary L, Vijayammal PL 1997. Effect of-nicotine on lipo-protein metabolism in rats. Lipids 32(3):311-315.
7. Asmussen I, Kjeldsen K. 1975. Intimal ultrastructure of human umbilical arteries. Observations on arteries from newborn children of smoking and nonsmoking mothers. Circ Res 36(5):579-589.
8. Barcin C, Tapan S, Kursaklioglu H, Iyisoy A, Olcay A; Erbil MK, et al. 2006. Effects of non-heavy smoking on high-density lipoprotein cholosterol in bealthy Turkish young men. Acta Cardiol 61(4):411-415.
9. Barker DJ. 2000. In utero programming of cardiovascular disease. Theriogenology 53:555-574.
10. Barker DJ, Winter PD, Osmond C, Margetts B, Simmonds SJ. 1989. Weight in infancy and death from ischaemic heart disease. Lancet 2(8663):577-580.
11. Berrahmoune H, Lamont J, Herbeth B, FitzGerald P, Visvikis-Siest S. 2006. Biological determinants of an reference values for plasma interleukin-8, monocyte chemoattractant protein-1, epidermal growth factor, and vascular endothelial growth factor: results from the STANISLAS cohort. Clin Chem 52:504-510.
12. Cohen MS. 2004. Fetal and childhood onset of adult cardiovascular diseases. Pediatr Clin North Am 51(6):1697-1719.
13. Curfs DM, Lutgens E, Gijbels MJ, Kockx MM, Daemen MJ, van Schooten FJ. 2004. Chronic exposure to the carcinogenic compound benzo[a]pyrene induces larger and phenotypically different atherosclerotic plaques in ApoE-knockout mice. Am J Pathol 164(1):101-108.
14. Dietert RR, Dietert JM. 2008. Possible role for early-life immune insult including developmental immunotoxicity in chronic fatigue syndrome (CFS) or myalgic encephalomyelitis (ME). Toxicology 247(1)61-72.
15. Eral O. 2004. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 37(4):277-285.
16. Fowden AL, Giussani DA, Forhead AJ. 2005. Endocrine and metabolic programming during intrauterine development. Early Hum Dev 81(9):723-734.
17. Gao YJ, Holloway AC, Zeng ZH, Lim GE, Petrik JJ, Foster WG, et al. 2005. Prenatal exposure to nicotine causes postnatal obesity and altered perivascular adipose tissue function. Obes Res 13.687-692.
18. Glass CK, Witztum JL. 2001. Atherosclerosis. the road ahead. Cell 104(4):503-516.
19. Gluckman PD, Hanson MA, Cooper C, Thornburg KL. 2008. Effect of in utero and early-life conditions on adult health and disease. N Engl J Med 359(1):61-73.
20. Gniwotta C, Morrow JD, Roberts LJ II, Kühn H. 1997. Prostaglandin F2-like compounds, F2-isoprostanes, are present in increased amounts in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol 17(11)3236-3241.
21. Godschalk R, Curfs D, Bartsch H, Van Schooten FJ, Nair J, 2003. Benzo[a]pyrene enhances lipid peroxidation induced DNA damage in aorta of apolipoprotein E knockout mice. Free Radic Res 37(12):1299-1305.
22. Hammad SM, Powell-Braxton L, Otvos JD, Eldridge L, Won W, Lyons TJ. 2003. Lipoprotein subclass profiles of hyperlipidemic diabetic mice measured by nuclear magnetic resonance spectroscopy. Metabolism 52(7),916-921.
23. Hoivoet P, Stassen JM, Cleemput JV, Collen D, Vanhaecke J. 1998. Oxidized low density lipoproteins in patients with transplant-associated coronary artery disease. Arterioscler Thromb Vasc Biol 18:100-107.
24. Hu FB, Stampfer MJ, Manson JE, Rimm E, Colditz GA, Rosner BA, et al. 1997. Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med 337(21):1491-1499.
25. Hutchison SJ, Glantz SA, Zhu BO, Sun YP, Chou TM, Chatterjee K, et al. 1998. In-utero and neonatal exposure to secondhand smoke causes vascular dysfunction in newborn rats. J Am Coll Candiol 32(5):1463-1467.
26. Işcan A, Yiǧitoǧlu MR, Ece A, Ari Z, Akyildiz M. 1997. The effect of cigarette smoking during pregnancy on cord blood lipid, lipoprotein and apolipoprotein levels. Jpn Heart J 38(4)497-502.
27. Jaddoe VW, de Ridder MA, van den Elzen AP, Hofman A, Uiterwaal CS, Witteman JC. 2008. Maternal smoking in pregnancy is associated with cholesterol development in the offspring: a 27-years follow-up study. Atherosclerosis 196(1):42-48.
28. Kane JK, Parker SL, Matta SG, Fu Y, Sharp BM, Li MD. 2000. Nicotine up-regulates expression of orexin and its receptors in rat brain. Endocrinology 141:3623-3629.
29. Koklu E, Kurtoglu S, Akcakus M, Koklu S, Buyukkayhan D, Gumus H, et al. 2006. Increased aortic intima-media thickness is related to lipid profile in newborns with intrauterine growth restriction. Horm Res 65(6):269-275.
30. Kovacs iB, Jahangiri M, Rees GM, Gorog P. 1997. Elevated plasma lipid hydroperoxides in patients with coronary artery disease. Am Heart J 134:572-576.
31. Kuller LH. 2008. Nutrition, lipids and cardiovascular disease: clinical benefits without biochemical effects and biochemical effects without clinical benefits. Curr Cardiovasc Risk Reports 2(1):9-14.
32. Kummerow FA, Olioescu RM, Fleischer L, Handler B, Shinkareva SV. 2000. The relationship of oxidized lipids to coronary artery stenosis. Atherosclerosis 149(1):181-190.
33. Li MD, Kane JK, Parker SL, McAllen K, Matta SG, Sharp BM. 2000. Nicotine administration enhances NPY expression in the rat hypothalamus. Brain Res 867:157-164.
34. Link JJ, Rohatgi A, de Lemos JA. 2007. HDL cholesterol: physiology, pathophysiology, and management. Curr Probl Cardiol 32(5):268-314.
35. Louey S, Thornburg KL. 2005. The prenatal environment and later cardiovascular disease. Early Hum Dev 81(9):745-751.
36. Lutgens E, Daemen MJ. 2002. CD40-CD40L interactions in atherosclerosis. Trends Cardiovasc Med 12(1):27-32.
37. March of Dimes. 2000. Smoking during Pregnancy. Wilkes-Barre, PA:March of Dimes Resource Center.
38. Martyn CN, Gale CR, Jespersen S, Sherriff SB. 1998. Impaired fetal growth and atherosclerosis of carotid and peripheral arteries. Lancet 352(9123):173-178.
39. Mosca L, Banka CL, Benjamin EJ, Berra K, Bushnell C, Dolor RJ, et al. 2007. Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. J Am Coll Cardiol 49(11):1230-1250.
40. Mosca L, Rubenfire M, Tarshis T, Tsai A, Pearson T. 1997. Clinical predictors of oxidized low-density lipoprotein in patients with coronay artery disease. Am J Cardiol 80(7):825-830.
41. Moskowitz WB, Mosteller M, Schieken RM, Bossano R, Hewitt JK, Bodurtha JN, et al. 1990. Lipoprotein and oxygen transport alterations in passive smoking preadolescent children. The MCV Twin Study. Circulation 81(2):586-592.
42. Navab M, Hama SY, Hough GP, Subbanagounder G, Reddy ST, Fogolman AM. 2001. A cell-free assay tor detecting HDL that is dysfunctional in preventing the formation of or inactivating oxidized hospholipids. J Lipid Res 42(8):1308-1317.
43. Ng SP, Silverstone AE, Lai ZW, Zelikoff JT. 2006. Effects of prenatal exposure to cigarette smoke on offspring tumor susceptibility and associated immune mechanisms. Toxicol Sci 89(1):135-144.
44. Noakes PS, Thomas R, Lane C, Mori TA, Barden AE, Devadason SG, et al. 2007. Association of maternal smoking with increased infant oxidative stress at 3 months of age. Thorax 62(8):714-717.
45. Pausová Z, Paus T, Sedová L, Bérubé J. 2003. Prenatal exposure to nicotine modifies kidney weight and blood pressure in genetically susceptible rats: a case of gene-environment interaction. Kidney Int 64(3):829-835.
46. Perera FP, Tang D, Tu YH, Cruz LA, Borjas M, Bernert T, et al. 2004. Biomarkers in maternal and newborn blood indicate heightened fetal susceptibility to procarcinogenic DNA damage. Environ Health Perspect 112:1133-1136.
47. Pryor WA, Stone K. 1993. Oxidants in cigarette smoke. Radicals; hydrogen peroxide, peroxynitrate, and peroxynitrite. Ann NY Acad Sci 686:12-27.
48. Ross R. 1993. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362:801-809.
49. Slotkin TA. 1998. Fetal nicotine or cocaine exposure: which one is worse? J Pharmacol Exp Ther 285:931-945.
50. Sviridov D, Mukhamedova N, Remaley AT, Chin-Dusting J, Nestel P. 2008. Antiatherogenic functionality of high density lipoprotein: how much versus how good. J Atheroscler Thromb 15(2):52-62.
51. Ueyama K, Yokode M, Arai H, Nagano Y, Li ZX, Cho M, et al. 1998. Cholesterol efflux effect of high density lipoprotein is impaired by whole cigarette smoke extracts through lipid peroxidation. Free Radic Biol Med 24(1):182-190.
52. Watson KE, Srikanthan P, Schreiner PJ, Post W, Burke GK, Casillas A, et al. 2007. High HDL-cholesterol levels are paradoxically associated with increased atherosclerosis and increased coronary heart disease (CHD) events in metabolic syndrome subjects: the Multi-ethnic Study of Atherosclerosis (MESA) [Abstract]. Circulation 116(11):540.
53. Yang Z, Harrison CM, Chuang GG, Ballinger SW. 2007. The role of tobacco smoke induced mitochondrial damage in vascular dysfunction and atherosclerosis. Mutat Res 821(1-2):61-74.
54. Zaratin AC, Quintão EC, Sposito AC. 2004. Smoking prevents the intravascular remodeling of high-density lipoprotein particles: implications for reverse cholesterol transport. Metabolism 53(7):858-862.